HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

D 53

ribosomal vaccine from Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes A(12) & Haemophilus influenzae

Also Known As:

MS D 53

Networked: 20 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Bacterial Vaccines: 529
      - Haemophilus Vaccines: 37
        D 53: 20
      - Streptococcal Vaccines: 12
        Pneumococcal Vaccines: 2006
        D 53: 20
        D 53: 20

Experts

1.	Dirlikov, Benjamin: 1 article (07/2020)
2.	Shem, Kazuko: 1 article (07/2020)
3.	Wong, Joseph: 1 article (07/2020)
4.	Altin, Cihan: 1 article (06/2019)
5.	Aydin, Elçin: 1 article (06/2019)
6.	Ağildere, Muhteşem: 1 article (06/2019)
7.	Tekindal, Mustafa Agah: 1 article (06/2019)
8.	Özcan Söylev, Gözde: 1 article (06/2019)
9.	Barnes, Deborah E: 1 article (01/2018)
10.	Chesney, Margaret A: 1 article (01/2018)

Related Diseases

1.	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/01/2018 - "Compared with WL, veterans randomized to IE demonstrated a greater reduction in PTSD symptom severity (d = -.90), a greater improvement in psychological quality of life (d = .53) and a smaller relative improvement in physical quality of life (d = .30) Veterans' ratings of IE indicated high feasibility and acceptability. " 01/01/2013 - "However, non-dippers endorsed more traumatic event categories (d = .53), more PTSD hyperarousal symptoms (d = .53), poorer overall sleep quality (d = .59), more frequent use of sleep medication (d = .62), greater sleep-related daytime dysfunction (d = .58), and longer sleep onset latencies (d = .55) than dippers. " 06/01/2012 - "Post-DST cortisol levels were lower in PTSD (d=-.40, SE=.12, p<.001), PTSD+MDD (d=-.65, SE=.14, p<.001), and TE groups (d=-.53, SE=.14, p<.001) relative to NTC. " 01/01/2023 - "Compared to participants who received CPT alone, those who received CBT-I&N and CPT, regardless of sequencing, demonstrated larger improvements in PTSD symptoms, d = -0.36; insomnia, d = -0.77; sleep efficiency, d = 0.62; and nightmares, d = -.53. "
2.	Infections 01/01/2018 - "First-time donors with chronic HBV-infection were often immigrants (67%) infected with genetically highly diverse strains of genotypes A (32%), B (8%), C (6%), D (53%) and E to H (1%). " 03/27/1995 - "We carried out a randomized prospective trial to compare OKT3 (5 mg/d, 51 patients) with ATG-Fresenius (ATG-F, 4 mg/kg/d, 53 patients) for induction therapy after renal transplantation, concerning side effects, rejection, and infection incidence within a one year follow-up period. "
3.	Cardiovascular Diseases (Cardiovascular Disease) 06/01/2019 - "The study population includes 52 patients with VDD (n = 30 [57% female], mean ± SD age 54.28 ± 8.77 years, mean ± SD serum 25-hydroxyvitamin D (25 [OH] D) 11 ± 2.4 ng/mL) and 82 participants for control group (n = 52 [63.4% female], mean ± SD age 56.40 ± 7.90 years, mean ± SD serum (25 [OH] D) 53 ± 4.2 ng/mL) who have no cardiovascular disease. "
4.	Body Weight (Weight, Body) 11/01/2015 - "For this purpose, 45 Holstein male calves (3d of age and 41 ± 3 kg of body weight) were randomly assigned to one of the following milk feeding groups: (1) conventional (CONV; 4 L/d milk from d 1 to 52, and 2 L/d milk from d 53 to 56 of the study), (2) STP (6 L/d milk from d 1 to 29, and 4 L/d milk from d 30 to 45 of the study followed by feeding 2L/d milk from d 46 to 56 of the study), and (3) SUSD (6 L/d milk from d 1 to 5, 8 L/d milk from d 6 to 15, 10 L/d milk from d 16 to 35, 8L/d milk from d 36 to 42, 6 L/d milk from d 43 to 47, 4 L/d milk from d 48 to 52 of the study followed by feeding 2 L/d milk from d 53 to 56 of the study). "
5.	Bacterial Infections (Bacterial Infection) 01/01/1980 - "Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology."

Related Drugs and Biologics

1.	Muromonab-CD3 (Muromonab CD3)
2.	Vaccines
3.	N 30
4.	hydroxide ion
5.	F 4 (F-4)
6.	Hydrocortisone (Cortisol)
7.	quinocarcin (D 52)
8.	51 C
9.	Yohimbine (Yocon)
10.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Kidney Transplantation
2.	Therapeutics
3.	Laser In Situ Keratomileusis (LASIK)